(2S,2\'\'S,3S,3\'\'R,4S)-3,4\',5,7-Tetrahydroxyflavan(2->7,4->8)-3,4\',5,7-tetrahydroxyflavan



Compound IDCDAMM00638
Common name(2S,2\'\'S,3S,3\'\'R,4S)-3,4\',5,7-Tetrahydroxyflavan(2->7,4->8)-3,4\',5,7-tetrahydroxyflavan
IUPAC name5,13-bis(4-hydroxyphenyl)-4,12,14-trioxapentacyclo[11.7.1.02,11.03,8.015,20]henicosa-2(11),3(8),9,15,17,19-hexaene-6,9,17,19,21-pentol
Molecular formulaC30H24O10

Experimental data

Retention time11.19
Adduct[M+H]+
Actual mz545.144
Theoretical mz545.144
Error0.23
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.77

Identifiers and class information

Inchi keyLQRHGTVFFPMWCG-UHFFFAOYNA-N
SmilesOC1=CC=C(C=C1)C2OC=3C(=C(O)C=C4OC5(OC=6C=C(O)C=C(O)C6C(C43)C5O)C7=CC=C(O)C=C7)CC2O
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)3
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)544.514
Computed dipole moment(dipole)5.434
Total solvent accessible surface area (SASA)774.187
Hydrophobic component of SASA (FOSA)77.961
Hydrophilic component of SASA (FISA)298.604
Pie component of the SASA (PISA)397.622
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1463.02
Number of hydrogen bond donors (donorHB)7
Number of hydrogen bond acceptors (accptHB)9.4
Free energy of solvation of dipole (dip^2/V)0.0201823
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0321241
Globularity descriptor (glob)0.805042
Predicted polarizability in cubic angstroms (QPpolrz)51.699
Predicted hexadecane/gas partition coefficient (QPlogPC16)18.314
Predicted octanol/gas partition coefficient (QPlogPoct)33.824
Predicted water/gas partition coefficient (QPlogPw)24.285
Predicted octanol/water partition coefficient (QPlogPo/w)1.987
Predicted aqueous solubility (QPlogS)-5.227
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.544
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.583
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)14.596
Predicted brain/blood partition coefficient (QPlogBB)-2.93
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)5.13
Predicted skin permeability, log Kp (QPlogKp)-4.95
PM3 calculated ionization potential (IP(ev))8.743
PM3 calculated electron affinity (EA(eV))-0.014
Number of likely metabolic reactions (#metab)10
Prediction of binding to human serum albumin (QPlogKhsa)0.153
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)33.499
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)167.69
Number of nitrogen and oxygen atoms (#NandO)10
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)2

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SwissTargetPrediction and SEA
P49763PGFPlacenta growth factorT70792SwissTargetPrediction and SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA
Q16678CYP1B1Cytochrome P450 1B1T92521SEA
P16152CBR1Carbonyl reductase [NADPH] 1T70518SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T70518DI0037Asthma[ICD-11: CA23]P16152CBR1

Copyright © 2025